M&A Deal Summary

Elysian Capital Acquires D3O

On September 20, 2021, private equity firm Elysian Capital acquired consumer products company D3O from Beringea

Acquisition Highlights
  • This is Elysian Capital’s 2nd transaction in the Consumer Products sector.
  • This is Elysian Capital’s 22nd transaction in the United Kingdom.

M&A Deal Summary

Date 2021-09-20
Target D3O
Sector Consumer Products
Buyer(s) Elysian Capital
Sellers(s) Beringea
Deal Type Secondary Buyout

Target

D3O

London, United Kingdom
website
D3O designs, manufactures, and distributes impact protection products to B2B customers around the globe. The D3O brand and the “Protected by D3O” Trustmark are synonymous with market-leading protection and quality. As such, the business has amassed an impressive portfolio of customers covering some of the World’s leading brands for protective equipment, across its key market segments of consumer protection (sport, outdoor, and electronics) and PPE (defense and industrial). D3O is based in London, United Kingdom.

Search 192,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elysian Capital

London, United Kingdom

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2007
PE ASSETS 700M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Elysian Capital LLP is an independent private equity firm that targets management buyouts of growing, profitable businesses throughout the UK. Elysian focuses on lower mid-market companies valued between £20 and £100 million. Sectors of interest include healthcare, local and central government, consumer/retail, utilities/renewable and financial/support services. Elysian Capital LLP was formed in 2007 and is based in London.


DEAL STATS #
Overall 23 of 25
Sector (Consumer Products) 2 of 2
Type (Secondary Buyout) 7 of 7
Country (United Kingdom) 22 of 23
Year (2021) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-08 Gravity

London, United Kingdom

Gravity is a digital marketing business serving a blue-chip customer base of businesses in B2B sectors and complex markets, across a range of industries including software, financial services, aerospace, industrials, pharma, and automotive. Gravity is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-09 Fastway Couriers

Dublin, Ireland

Fastway Couriers is a parcel courier businesses in Ireland. Fastway Couriers was founded in 2002 and is based in Dublin, Ireland.

Buy -

Seller(S) 1

SELLER

Beringea

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1988
PE ASSETS 715M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Beringea LLP is a private equity firm focused on growth-oriented company investments in the Midwest US and the UK. Beringea looks to invest $2 to $10 million of equity or junior capital in profitable companies with 5 million and higher in revenue. Funds are used to support business expansions and growth, ownership transitions, leveraged buyouts, recapitalization, and refinancings. The Firm does not have any sector preferences and generally seeks businesses with proven business models and defensible market positions. Beringea was formed in 1988 and is based in London.


DEAL STATS #
Overall 30 of 39
Sector (Consumer Products) 2 of 2
Type (Secondary Buyout) 7 of 9
Country (United Kingdom) 17 of 23
Year (2021) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-07 ContactEngine

London, United Kingdom

ContactEngine is a cloud-hosted customer-conversation management platform. Pro-active and omnichannel, ContactEngine leverages natural-language processing and machine-learning so that global brands can transform their customer journeys. ContactEngine was founded in 2009 and is based in London, United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-13 Akadeum Life Science

Ann Arbor, Michigan, United States

Akadeum Life Science is a microbubble-based separation platform, with applications spanning life science research, including cell therapy and diagnostics. Akadeum Life Science is based in Ann Arbor, Michigan.

Buy -